BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 33611903)

  • 1. [Analyses of triggers for recurrent cardiac events in 38 patients with symptomatic long QT syndrome].
    Li K; She F; Yang J; Liu YW; He R; Xie Y; Zhou BD; Lyu TT; Xu BH; Liu FL; Liu F; Zhang P
    Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Feb; 49(2):165-169. PubMed ID: 33611903
    [No Abstract]   [Full Text] [Related]  

  • 2. Contemporary Outcomes in Patients With Long QT Syndrome.
    Rohatgi RK; Sugrue A; Bos JM; Cannon BC; Asirvatham SJ; Moir C; Owen HJ; Bos KM; Kruisselbrink T; Ackerman MJ
    J Am Coll Cardiol; 2017 Jul; 70(4):453-462. PubMed ID: 28728690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The long-term efficacy of left cardiac sympathetic denervation in long QT syndrome].
    Li X; Li CL; Liu YG; Liu JY; Wang JF; Li ZM; Ma DY; Hu D
    Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Jun; 50(6):556-562. PubMed ID: 35705464
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical aspects of the three major genetic forms of long QT syndrome (LQT1, LQT2, LQT3).
    Kutyifa V; Daimee UA; McNitt S; Polonsky B; Lowenstein C; Cutter K; Lopes C; Zareba W; Moss AJ
    Ann Noninvasive Electrocardiol; 2018 May; 23(3):e12537. PubMed ID: 29504689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left cardiac sympathetic denervation in long QT syndrome: analysis of therapeutic nonresponders.
    Bos JM; Bos KM; Johnson JN; Moir C; Ackerman MJ
    Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):705-11. PubMed ID: 23728945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Automated external defibrillator rescues among children with diagnosed and treated long QT syndrome.
    Pundi KN; Bos JM; Cannon BC; Ackerman MJ
    Heart Rhythm; 2015 Apr; 12(4):776-81. PubMed ID: 25576780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left cardiac sympathetic denervation for the management of life-threatening ventricular tachyarrhythmias in young patients with catecholaminergic polymorphic ventricular tachycardia and long QT syndrome.
    Schneider HE; Steinmetz M; Krause U; Kriebel T; Ruschewski W; Paul T
    Clin Res Cardiol; 2013 Jan; 102(1):33-42. PubMed ID: 22821214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implantable cardioverter-defibrillator therapy in patients with congenital long-QT syndrome: a long-term follow-up.
    Mönnig G; Köbe J; Löher A; Eckardt L; Wedekind H; Scheld HH; Haverkamp W; Milberg P; Breithardt G; Schulze-Bahr E; Böcker D
    Heart Rhythm; 2005 May; 2(5):497-504. PubMed ID: 15840474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of different beta-blockers in the treatment of long QT syndrome.
    Abu-Zeitone A; Peterson DR; Polonsky B; McNitt S; Moss AJ
    J Am Coll Cardiol; 2014 Sep; 64(13):1352-8. PubMed ID: 25257637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotype Predicts Outcomes in Fetuses and Neonates With Severe Congenital Long QT Syndrome.
    Moore JP; Gallotti RG; Shannon KM; Bos JM; Sadeghi E; Strasburger JF; Wakai RT; Horigome H; Clur SA; Hill AC; Shah MJ; Behere S; Sarquella-Brugada G; Czosek R; Etheridge SP; Fischbach P; Kannankeril PJ; Motonaga K; Landstrom AP; Williams M; Patel A; Dagradi F; Tan RB; Stephenson E; Krishna MR; Miyake CY; Lee ME; Sanatani S; Balaji S; Young ML; Siddiqui S; Schwartz PJ; Shivkumar K; Ackerman MJ
    JACC Clin Electrophysiol; 2020 Nov; 6(12):1561-1570. PubMed ID: 33213816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Significance of Early Repolarization in Long QT Syndrome.
    Sugrue A; Rohatgi RK; Bos M; Vaidya VR; Asirvatham SJ; Noseworthy PA; Ackerman MJ
    JACC Clin Electrophysiol; 2018 Sep; 4(9):1238-1244. PubMed ID: 30236400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QT interval prolongation and risk for cardiac events in genotyped LQTS-index children.
    Wedekind H; Burde D; Zumhagen S; Debus V; Burkhardtsmaier G; Mönnig G; Breithardt G; Schulze-Bahr E
    Eur J Pediatr; 2009 Sep; 168(9):1107-15. PubMed ID: 19101729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome.
    Schwartz PJ; Priori SG; Cerrone M; Spazzolini C; Odero A; Napolitano C; Bloise R; De Ferrari GM; Klersy C; Moss AJ; Zareba W; Robinson JL; Hall WJ; Brink PA; Toivonen L; Epstein AE; Li C; Hu D
    Circulation; 2004 Apr; 109(15):1826-33. PubMed ID: 15051644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Jervell and Lange-Nielsen syndrome; atrial pacing combined with ß-blocker therapy, a favorable approach in young high-risk patients with long QT syndrome?
    Früh A; Siem G; Holmström H; Døhlen G; Haugaa KH
    Heart Rhythm; 2016 Nov; 13(11):2186-2192. PubMed ID: 27451284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-blocker efficacy in high-risk patients with the congenital long-QT syndrome types 1 and 2: implications for patient management.
    Goldenberg I; Bradley J; Moss A; McNitt S; Polonsky S; Robinson JL; Andrews M; Zareba W;
    J Cardiovasc Electrophysiol; 2010 Aug; 21(8):893-901. PubMed ID: 20233272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulating effects of age and gender on the clinical course of long QT syndrome by genotype.
    Zareba W; Moss AJ; Locati EH; Lehmann MH; Peterson DR; Hall WJ; Schwartz PJ; Vincent GM; Priori SG; Benhorin J; Towbin JA; Robinson JL; Andrews ML; Napolitano C; Timothy K; Zhang L; Medina A;
    J Am Coll Cardiol; 2003 Jul; 42(1):103-9. PubMed ID: 12849668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias.
    Schwartz PJ; Priori SG; Spazzolini C; Moss AJ; Vincent GM; Napolitano C; Denjoy I; Guicheney P; Breithardt G; Keating MT; Towbin JA; Beggs AH; Brink P; Wilde AA; Toivonen L; Zareba W; Robinson JL; Timothy KW; Corfield V; Wattanasirichaigoon D; Corbett C; Haverkamp W; Schulze-Bahr E; Lehmann MH; Schwartz K; Coumel P; Bloise R
    Circulation; 2001 Jan; 103(1):89-95. PubMed ID: 11136691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-blocker therapy failures in symptomatic probands with genotyped long-QT syndrome.
    Chatrath R; Bell CM; Ackerman MJ
    Pediatr Cardiol; 2004; 25(5):459-65. PubMed ID: 15534720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics and genetic background of congenital long-QT syndrome diagnosed in fetal, neonatal, and infantile life: a nationwide questionnaire survey in Japan.
    Horigome H; Nagashima M; Sumitomo N; Yoshinaga M; Ushinohama H; Iwamoto M; Shiono J; Ichihashi K; Hasegawa S; Yoshikawa T; Matsunaga T; Goto H; Waki K; Arima M; Takasugi H; Tanaka Y; Tauchi N; Ikoma M; Inamura N; Takahashi H; Shimizu W; Horie M
    Circ Arrhythm Electrophysiol; 2010 Feb; 3(1):10-7. PubMed ID: 19996378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Videoscopic left cardiac sympathetic denervation for patients with recurrent ventricular fibrillation/malignant ventricular arrhythmia syndromes besides congenital long-QT syndrome.
    Coleman MA; Bos JM; Johnson JN; Owen HJ; Deschamps C; Moir C; Ackerman MJ
    Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):782-8. PubMed ID: 22787014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.